Patent · US Active

Peptides and methods for the treatment of diabetes

US11407795B2 · kind B2 · utility

2Cited by

6References

5Claims

0Family size

Assignee

IMCYSE SA · BE

Inventors

Luc Vander Elst · Obaix, BE
Vincent Carlier · Énines, BE
Jean-Marie Saint-Remy · Grez-Doiceau, BE

Key dates

Filing date	Sep 14, 2020
Grant date	Aug 9, 2022
Priority date	—
Expiry date	Sep 14, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/577
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to peptides such as HCPYCSLQPLALEGSLQKRG [SEQ ID NO: 26] and their use in the treatment of type 1 diabetes and the generation of cytolytic CD4+ T cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.